All Stories

  1. RTN4IP1 Mutation and Endocrine Failure: Clinical Features and Possible Benefits of Coenzyme Q10
  2. Unveiling the complexities of hypoparathyroidism: a comprehensive review of clinical manifestations, diagnosis, and novel therapies
  3. Thyroid Nodule Surveillance in Transfusion-Dependent Thalassemia: A Comparative Ultrasonographic Study
  4. Increased mortality in primary adrenal insufficiency: a systematic review and meta-analysis
  5. Tumor Inflammatory Microenvironment of the Thyroid Cancer: Relationship between Regulatory T-Cell Imbalance, and p-NFΚB (p65) Expression—A Preliminary Study
  6. Increased prevalence of nodular thyroid disease in patients with Klinefelter syndrome
  7. Nodular thyroid disease and low FT4 levels in Klinefelter syndrome: an extension of the classical phenotype
  8. X-linked hypophosphatemic rickets: cases series and literature review with a focus on neurosurgical management
  9. Patients with DeSanto–Shinawi syndrome: Further extension of phenotype from Italy
  10. First baseline data of the Klinefelter ItaliaN Group (KING) cohort: clinical features of adult with Klinefelter syndrome in Italy
  11. Graves' dermopathy during Covid 19 pandemic
  12. Quality of life in Klinefelter patients on testosterone replacement therapy compared to healthy controls: an observational study on the impact of psychological distress, personality traits, and coping strategies
  13. Increased platelet reactivity in Klinefelter men: something new to consider
  14. Maternal hypothyroidism and subsequent neuropsychological outcome of the progeny: a family portrait
  15. Testicular parenchymal abnormalities in Klinefelter syndrome: a question of cancer? Examination of 40 consecutive patients
  16. Long-term outcomes of laparoscopic adrenalectomy for Cushing disease
  17. Impact of prophylactic central compartment neck dissection on locoregional recurrence of differentiated thyroid cancer in clinically node-negative patients: A retrospective study of a large clinical series
  18. Current concepts of pheochromocytoma
  19. The role of surgery in the current management of differentiated thyroid cancer
  20. The Role of Survivin in Thyroid Tumors: Differences of Expression in Well-Differentiated, Non–Well-Differentiated, and Anaplastic Thyroid Cancers
  21. Prognostic implications of node metastatic features in OSCC: a retrospective study on 121 neck dissections
  22. Cardiovascular abnormalities in Klinefelter Syndrome
  23. High circulating levels of CCL2 in patients with Klinefelter's syndrome
  24. Laparoscopic adrenalectomy, a safe procedure for pheochromocytoma. A retrospective review of clinical series
  25. Total thyroidectomy, without prophylactic central lymph node dissection, in the treatment of differentiated thyroid cancer. Clinical retrospective study on 221 cases
  26. Predictive value of nodal metastases on local recurrence in the management of differentiated thyroid cancer. Retrospective clinical study
  27. Multifocal thoracic chordoma mimicking a paraganglioma
  28. Laparoscopic adrenal surgery: ten-year experience in a single institution
  29. Lessons to be learned from the clinical management of a MEN 2A patient bearing a novel 634/640/700 mutation of theRETproto-oncogene
  30. A Unique Patient Presenting With Concomitant Klinefelter Syndrome, Alport Syndrome, and Craniopharyngioma
  31. Epigenetic fingerprint in endometrial carcinogenesis: The hypothesis of a uterine field cancerization
  32. Upregulation of Endocrine Gland-Derived Vascular Endothelial Growth Factor in Papillary Thyroid Cancers Displaying Infiltrative Patterns, Lymph Node Metastases, and BRAF Mutation
  33. CDKN1B V109G polymorphism a new prognostic factor in sporadic medullary thyroid carcinoma
  34. Expression of RIZ1 protein (Retinoblastoma-interacting zinc-finger protein 1) in prostate cancer epithelial cells changes with cancer grade progression and is modulated in vitro by DHT and E2
  35. Effect of long-term cabergoline therapy on the immunological pattern and pituitary function of patients with idiopathic hyperprolactinaemia positive for antipituitary antibodies
  36. Survivin gene-expression and splicing isoforms in oral squamous cell carcinoma
  37. Effects of somatostatin analogue SOM230 on cell proliferation, apoptosis and catecholamines levels in cultured pheochromocytoma cells
  38. Antipituitary Antibodies against Gonadotropin-Secreting Cells in Adult Male Patients with Apparently Idiopathic Hypogonadotropic Hypogonadism
  39. The Endocrine-Gland-Derived Vascular Endothelial Growth Factor (EG-VEGF)/Prokineticin 1 and 2 and Receptor Expression in Human Prostate: Up-Regulation of EG-VEGF/Prokineticin 1 with Malignancy
  40. Natural and Synthetic Retinoids in Prostate Cancer
  41. Characterization of antipituitary antibodies targeting pituitary hormone-secreting cells in idiopathic growth hormone deficiency and autoimmune endocrine diseases
  42. Differential effects of all-trans-retinoic acid (RA) on Erk1/2 phosphorylation and cAMP accumulation in normal and malignant human prostate epithelial cells: Erk1/2 inhibition restores RA-induced decrease of cell growth in malignant prostate cells
  43. Fenofibrate increases the expression of high mobility group AT-hook 2 (HMGA2) gene and induces adipocyte differentiation of orbital fibroblasts from Graves' ophthalmopathy
  44. Verapamil inhibits interleukin-6 and vascular endothelial growth factor production in primary cultures of keloid fibroblasts
  45. All-trans retinoic acid- and N-(4-hydroxyphenil)-retinamide-induced growth arrest and apoptosis in orbital fibroblasts in Graves’ disease
  46. Loss of oestrogen receptor beta, high PCNA and p53 expression and aneuploidy as markers of worse prognosis in ovarian granulosa cell tumours
  47. Somatostatin Receptor Genes Are Expressed in Lymphocytes from Retroorbital Tissues in Graves’ Disease
  48. EPN: A NOVEL EPITHELIAL CELL LINE DERIVED FROM HUMAN PROSTATE TISSUE
  49. Estrogen receptor β expression in human prostate tissue
  50. Loss of Estrogen Receptor   Expression in Malignant Human Prostate Cells in Primary Cultures and in Prostate Cancer Tissues
  51. ANTISPERM ANTIBODIES IN CRYPTORCHIDISM BEFORE AND AFTER SURGERY
  52. Endocrine Secretions under Abnormal Light-Dark Cycles and in the Blind
  53. Retinoic acid receptors alpha, beta and gamma, and cellular retinol binding protein-I expression in breast fibrocystic disease and cancer
  54. Different Expression Patterns of Somatostatin Receptor Subtypes in Cultured Epithelial Cells from Human Normal Prostate and Prostate Cancer
  55. Abnormal level of retinoic acid in prostate cancer tissues
  56. Late Gonadal Function and Autoimmunization in Familial Testicular Torsion